| For: | Pozzato G, Mazzaro C, Dal Maso L, Mauro E, Zorat F, Moratelli G, Bulian P, Serraino D, Gattei V. Hepatitis C virus and non-Hodgkin’s lymphomas: Meta-analysis of epidemiology data and therapy options. World J Hepatol 2016; 8(2): 107-116 [PMID: 26807206 DOI: 10.4254/wjh.v8.i2.107] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i2/107.htm |
| Number | Citing Articles |
| 1 |
Ben Ponvilawan, Thanitsara Rittiphairoj, Nipith Charoenngam, Pongprueth Rujirachun, Phuuwadith Wattanachayakul, Surapa Tornsatitkul, Patompong Ungprasert. Association Between Chronic Hepatitis C Virus Infection and Esophageal Cancer. Journal of Clinical Gastroenterology 2022; 56(1) doi: 10.1097/MCG.0000000000001532
|
| 2 |
Clara Young, Mandeep Singh, Katherine J.L. Jackson, Matt A. Field, Timothy J. Peters, Stefano Angioletti-Uberti, Daan Frenkel, Shyamsundar Ravishankar, Money Gupta, Jing J. Wang, David Agapiou, Megan L. Faulks, Ghamdan Al-Eryani, Fabio Luciani, Tom P. Gordon, Joanne H. Reed, Mark Danta, Andrew Carr, Anthony D. Kelleher, Gregory J. Dore, Gail Matthews, Robert Brink, Rowena A. Bull, Dan Suan, Christopher C. Goodnow. A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease. Immunity 2025; 58(2) doi: 10.1016/j.immuni.2024.12.011
|
| 3 |
Stanislas Pol, Anaïs Vallet-Pichard, Olivier Hermine. Extrahepatic cancers and chronic HCV infection. Nature Reviews Gastroenterology & Hepatology 2018; 15(5) doi: 10.1038/nrgastro.2017.172
|
| 4 |
Laura Milazzo, Lorena van den Bogaart, Salvatore Sollima, Letizia Oreni, Alessia Lai, Valentina Morena, Cecilia Bonazzetti, Lisa Ridolfo Anna, Spinello Antinori. Impact of HCV eradication with direct-acting antiviral agents on serum gamma globulin levels in HCV and HCV/HIV coinfected patients. European Journal of Internal Medicine 2020; 75 doi: 10.1016/j.ejim.2020.01.006
|
| 5 |
Haiping Chen, Pei Du, Tianyao Yang, Xueyuan Xu, Tianyang Cui, Yuhang Dai. Hepatitis C virus infection is associated with high risk of breast cancer: a pooled analysis of 68,014 participants. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1274340
|
| 6 |
Stanislas Pol, Sylvie Lagaye. The remarkable history of the hepatitis C virus. Genes & Immunity 2019; 20(5) doi: 10.1038/s41435-019-0066-z
|
| 7 |
L. Gragnani, G. Cerretelli, S. Lorini, C. Steidl, A. Giovannelli, M. Monti, L. Petraccia, S. Sadalla, T. Urraro, P. Caini, A. Xheka, A. Simone, U. Arena, M. Matucci‐Cerinic, D. Vergani, G. Laffi, A. L. Zignego. Interferon‐free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis. Alimentary Pharmacology & Therapeutics 2018; 48(4) doi: 10.1111/apt.14845
|
| 8 |
Juan Pablo Alderuccio, Alexandra Stefanovic, Daniel Dammrich, Jennifer R. Chapman, Francisco Vega, Gennaro Selvaggi, Andreas Tzakis, Izidore S. Lossos. Decreased survival in hepatitis C patients with monomorphic post-transplant lymphoproliferative disorder after liver transplantation treated with frontline immunochemotherapy. Leukemia & Lymphoma 2018; 59(9) doi: 10.1080/10428194.2017.1413187
|
| 9 |
Stanislas Pol, Lucia Parlati, Michel Jadoul. Hepatitis C virus and the kidney. Nature Reviews Nephrology 2019; 15(2) doi: 10.1038/s41581-018-0081-8
|
| 10 |
Emilio Iannitto, Catherine Thieblemont. Indolent Lymphomas. Hematologic Malignancies 2021; doi: 10.1007/978-3-030-55989-2_9
|
| 11 |
Sarah Aherfi, Philippe Colson, Gilles Audoly, Claude Nappez, Luc Xerri, Audrey Valensi, Matthieu Million, Hubert Lepidi, Regis Costello, Didier Raoult. Marseillevirus in lymphoma: a giant in the lymph node. The Lancet Infectious Diseases 2016; 16(10) doi: 10.1016/S1473-3099(16)30051-2
|
| 12 |
Q. Riller, F. Cohen-Aubart, D. Roos-Weil. Lymphomes spléniques : diagnostic et prise en charge. La Revue de Médecine Interne 2022; 43(10) doi: 10.1016/j.revmed.2022.05.009
|
| 13 |
Busara Songtanin, Kenneth Nugent. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection. Biology 2022; 12(1) doi: 10.3390/biology12010023
|
| 14 |
C.‐E. Huang, Y.‐H. Yang, Y.‐Y. Chen, J.‐J. Chang, K.‐J. Chen, C.‐H. Lu, K.‐D. Lee, P.‐C. Chen, C.‐C. Chen. The impact of hepatitis B virus infection and vaccination on the development of non‐Hodgkin lymphoma. Journal of Viral Hepatitis 2017; 24(10) doi: 10.1111/jvh.12713
|
| 15 |
Tarek Saadi, Johad Khoury. Is There a Relationship Between Treatment With Direct Antiviral Agents for HCV Infection and the Development of Malignancies?. Journal of Clinical Gastroenterology 2018; 52(4) doi: 10.1097/MCG.0000000000000853
|
| 16 |
María Laura Polo, Natalia Laufer. Extrahepatic manifestations of HCV: the role of direct acting antivirals. Expert Review of Anti-infective Therapy 2017; 15(8) doi: 10.1080/14787210.2017.1354697
|
| 17 |
Gabriele Pozzato, Cesare Mazzaro, Valter Gattei. Hepatitis C Virus–Associated Non-Hodgkin Lymphomas. Clinics in Liver Disease 2017; 21(3) doi: 10.1016/j.cld.2017.03.006
|
| 18 |
Francesco Bertoni, Davide Rossi, Markus Raderer, Emanuele Zucca. Marginal Zone Lymphomas. The Cancer Journal 2020; 26(4) doi: 10.1097/PPO.0000000000000463
|
| 19 |
Marine Armand, Caroline Besson, Olivier Hermine, Frédéric Davi. Hepatitis C virus – Associated marginal zone lymphoma. Best Practice & Research Clinical Haematology 2017; 30(1-2) doi: 10.1016/j.beha.2017.02.001
|
| 20 |
Francesco Bertoni, Davide Rossi, Emanuele Zucca. Recent advances in understanding the biology of marginal zone lymphoma. F1000Research 2018; 7 doi: 10.12688/f1000research.13826.1
|
| 21 |
Clémence Hollande, Lucia Parlati, Stanislas Pol. Micro‐elimination of hepatitis C virus. Liver International 2020; 40(S1) doi: 10.1111/liv.14363
|
| 22 |
Charlotte Lybeck, Daniel Bruce, Scott M. Montgomery, Soo Aleman, Ann‐Sofi Duberg. Risk of extrahepatic cancer in a nationwide cohort of hepatitis C virus infected persons treated with direct‐acting antivirals. GastroHep 2021; 3(3) doi: 10.1002/ygh2.456
|
| 23 |
Michele Magoni, Francesco Donato, Pietro Apostoli, Giuseppe Rossi, Pietro Comba, Lucia Fazzo, Fabrizio Speziani, Lucia Leonardi, Grazia Orizio, Carmelo Scarcella, Antonella Anastasia, Alessandra Tucci. Serum levels of polychlorinated biphenyls and risk of non-Hodgkin lymphoma: A hospital-based case-control study.. Chemosphere 2019; 235 doi: 10.1016/j.chemosphere.2019.06.193
|
| 24 |
Johad Khoury, George Nassar, Rimma Kramsky, Tarek Saadi. Extrahepatic Malignancies After Treatment with Direct Antiviral Agents for Chronic HCV Infection. Journal of Gastrointestinal Cancer 2020; 51(2) doi: 10.1007/s12029-019-00293-y
|
| 25 |
Arpan Mohanty, Sarah Salameh, Adeel A. Butt. Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection. Current HIV/AIDS Reports 2019; 16(5) doi: 10.1007/s11904-019-00466-1
|
| 26 |
Cesare Mazzaro, Luigino Dal Maso, Endri Mauro, Marcella Visentini, Maurizio Tonizzo, Valter Gattei, Pietro Andreone, Gabriele Pozzato. Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy. Autoimmunity Reviews 2020; 19(8) doi: 10.1016/j.autrev.2020.102589
|
| 27 |
Stanislas Pol. Virus de l’hépatite C : une élimination programmable. La Presse Médicale 2019; 48(1) doi: 10.1016/j.lpm.2019.01.001
|
| 28 |
Alessia CIANCIO. Impact of direct antiviral agents (DAAs) on B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C. Minerva Gastroenterology 2021; 67(3) doi: 10.23736/S2724-5985.21.02834-8
|
| 29 |
|
| 30 |
Shunji Hirose, Yoko Yamaji, Kota Tsuruya, Yoshiaki Ogawa, Masashi Miyaoka, Tatehiro Kagawa. Rapid Regression of B-Cell Non-Hodgkin’s Lymphoma after Eradication of Hepatitis C Virus by Direct Antiviral Agents. Case Reports in Gastroenterology 2019; 13(2) doi: 10.1159/000501546
|
| 31 |
Daniele Borsetto, Jonathan Fussey, Luca Fabris, Luigia Bandolin, Piergiorgio Gaudioso, Veronica Phillips, Jerry Polesel, Paolo Boscolo-Rizzo. HCV infection and the risk of head and neck cancer: A meta-analysis. Oral Oncology 2020; 109 doi: 10.1016/j.oraloncology.2020.104869
|
| 32 |
Alexia Anastasia Stefania Balta, Mariana Daniela Ignat, Raisa Eloise Barbu, Caterina Dumitru, Diana Sabina Radaschin, Valentin Bulza, Silvia Aura Mateescu Costin, Catalin Pleșea-Condratovici, Liliana Baroiu. Impact of Direct-Acting Antivirals on Extrahepatic Manifestations in Chronic Hepatitis C: A Narrative Review with a Hermeneutic Approach. Healthcare 2025; 13(16) doi: 10.3390/healthcare13161953
|
| 33 |
Luca Aresu, Stefano Comazzi, Laura Marconato, Francesco Bertoni. Schalm's Veterinary Hematology. 2022; doi: 10.1002/9781119500537.ch69
|
| 34 |
L. Couronné, E. Bachy, S. Roulland, B. Nadel, F. Davi, M. Armand, D. Canioni, J.M. Michot, C. Visco, L. Arcaini, C. Besson, O. Hermine. From hepatitis C virus infection to B-cell lymphoma. Annals of Oncology 2018; 29(1) doi: 10.1093/annonc/mdx635
|
| 35 |
|
| 36 |
A. Schiavinato, A. Zanetto, G. Pantano, F. Tosato, M. Nabergoj, P. Fogar, E. Piva, M. Gambato, E. Franceschet, A. Floreani, F. Farinati, P. Burra, F. P. Russo, M. Plebani. Polyclonal and monoclonal B lymphocytes response in HCV‐infected patients treated with direct‐acting antiviral agents. Journal of Viral Hepatitis 2017; 24(12) doi: 10.1111/jvh.12746
|
| 37 |
Adriano Pellicelli, Valerio Giannelli, Valerio Zoli, Giovanni Regine, Andrea Cortese, Giuseppe M Ettorre, Enrico Carmenini, Valeria Pellicelli, Luigi Rigacci. Resolution of primary hepatic marginal zone lymphoma in a hepatitis C virus-infected patient treated with a direct-acting antiviral. Oxford Medical Case Reports 2021; 2021(5) doi: 10.1093/omcr/omab022
|
| 38 |
|
| 39 |
D. A. Lioznov, M. S. Nozhkin, O. V. Gorchakova, T. V. Antonova. Characteristics of HCV infection in oncohematological patients. Journal Infectology 2020; 12(1) doi: 10.22625/2072-6732-2020-12-1-91-95
|
| 40 |
Lorenza Lia, Daniela Grima, Francesca Amici, Linda Manzi, Alessandro Monaci, Giuseppe La Torre. The Possible Protective Effect of Hepatitis B Vaccine against Lymphomas: A Systematic Review. Current Pharmaceutical Biotechnology 2022; 23(15) doi: 10.2174/1389201023666220113111946
|
| 41 |
Sophia S. Wang. Epidemiology and etiology of diffuse large B-cell lymphoma. Seminars in Hematology 2023; 60(5) doi: 10.1053/j.seminhematol.2023.11.004
|
| 42 |
Stanislas Pol, Sylvie Lagaye. The remarkable history of the hepatitis C virus. Microbes and Infection 2019; 21(5-6) doi: 10.1016/j.micinf.2019.06.008
|
| 43 |
Ekaterina Borisovna Rodionova. THE ROLE OF SALIVARY GLAND BIOPSY IN DIAGNOSIS OF SYSTEMIC DISEASES AND THEIR LYMPHOPROLIFERATIVE COMPLICATIONS. Russian Journal of Dentistry 2017; 21(4) doi: 10.18821/1728-2802-2017-21-4-218-224
|
| 44 |
Mikhail S. Nozhkin, Dmitry A. Lioznov, Tamara V. Antonova, Olga V. Gorchakova, Edward M. Goldstein, Marina O. Popova, Tatyana V. Shneyder. Prognostic factors in patients with hematological malignancies and concomitant chronic hepatitis C. Terapevticheskii arkhiv 2023; 95(11) doi: 10.26442/00403660.2023.11.202473
|
| 45 |
Tamara Vasilevna Antonova, M. S. Nozhkin, D. A. Lioznov. Chronic Hepatitis С and Oncohematological Diseases. Clinical Oncohematology 2024; 16(1) doi: 10.21320/2500-2139-2023-16-1-46-53
|
| 46 |
Carlo Visco, Luca Arcaini, Giuseppe Carli, Michele Merli. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma. World Journal of Gastroenterology 2016; 22(38): 8447-8458 doi: 10.3748/wjg.v22.i38.8447
|
| 47 |
Irene Defrancesco, Caterina Zerbi, Sara Rattotti, Michele Merli, Raffaele Bruno, Marco Paulli, Luca Arcaini. HCV infection and non-Hodgkin lymphomas: an evolving story. Clinical and Experimental Medicine 2020; 20(3) doi: 10.1007/s10238-020-00615-6
|
| 48 |
Katsushi Tajima, Naoto Takahashi, Kenichi Ishizawa, Kazunori Murai, Tomoaki Akagi, Hideyoshi Noji, Osamu Sasaki, Masaharu Wano, Jugoh Itoh, Yuichi Kato, Tsutomu Shichishima, Hideo Harigae, Yoji Ishida. Clinicopathological characteristics of malignant lymphoma in patients with hepatitis C virus infection in the Tohoku district in Eastern Japan. Leukemia & Lymphoma 2017; 58(6) doi: 10.1080/10428194.2016.1236376
|
| 49 |
Guido Carloni, Daniela Fioretti, Monica Rinaldi, Antonio Ponzetto. Heterogeneity and coexistence of oncogenic mechanisms involved in HCV-associated B-cell lymphomas. Critical Reviews in Oncology/Hematology 2019; 138 doi: 10.1016/j.critrevonc.2019.04.005
|
| 50 |
Harrys A. Torres, Terri Lynn Shigle, Nassim Hammoudi, James T. Link, Felipe Samaniego, Ahmed Kaseb, Vincent Mallet. The oncologic burden of hepatitis C virus infection: A clinical perspective. CA: A Cancer Journal for Clinicians 2017; 67(5) doi: 10.3322/caac.21403
|